ArticleMaterials today. Bio2025
Neuroactive network tissue based on dual-factor neuroregenerative bioactive coating scaffolds and neural stem cells for spinal cord injury repair.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Research Progress on Biomaterial Scaffolds Carrying Stem Cells for Inflammation Regulation After Spinal Cord Injury.Stem cell reviews and reports · 2026Review
- Transcriptomics Insights into Spinal Cord Injury for Therapy Development.International journal of molecular sciences · 2026Review
- Mechanical Remodeling and Mechanosensing after Spinal Cord Injury: From Molecular to Translational Approaches.Research (Washington, D.C.) · 2026Review
- rTMS-induced motor cortex activation drives neural network tissueoid mediated spinal motor neural pathway reconstruction.Theranostics · 2026Article
- Endoplasmic reticulum stress-mediated cell death in spinal cord injury: from molecular mechanisms to therapeutic applications.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury (SCI) results in sensory and motor dysfunction, with neuronal death, circuit disruption, and the inhibitory microenvironment serving as key limitations to effective treatment. In this study, we developed a neuroactive network tissue for SCI repair by immobilizing dual recombinant growth factors based on biomimetic mussel adhesive units onto an oriented electrospun nanofiber scaffold, and seeding neural stem cells (NSCs) onto the scaffold. This dual-factor system continuously stimulates and enhances the paracrine function of NSCs, promoting repair of the injury site. In the early stages, the neurorepair coating amplifies the paracrine effects of NSCs, alleviating oxidative stress and inflammation while inhibiting neuronal cell death. In the later stages, it facilitates neurogenesis, axon growth, and neural circuit restoration. Single-cell RNA sequencing further reveals that the treatment reduces immune cell activation, promotes the survival of neurons and oligodendrocytes, sequentially and multidimensionally improves the local microenvironment, and enhances tissue regeneration. Both in vitro and in vivo experiments confirms that the neural active network effectively reshapes the immune environment at the injury site, boosting cell differentiation and repair, and thus providing a comprehensive strategy for tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.